SANUWAVE Health, Inc. Common Stock (SNWV) - Total Liabilities

Latest as of March 2026: $35.26 Million USD

Based on the latest financial reports, SANUWAVE Health, Inc. Common Stock (SNWV) has total liabilities worth $35.26 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See working capital to net assets of SANUWAVE Health, Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.

SANUWAVE Health, Inc. Common Stock - Total Liabilities Trend (2006–2025)

This chart illustrates how SANUWAVE Health, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see SANUWAVE Health, Inc. Common Stock asset portfolio.

SANUWAVE Health, Inc. Common Stock Competitors by Total Liabilities

The table below lists competitors of SANUWAVE Health, Inc. Common Stock ranked by their total liabilities.

Company Country Total Liabilities
Global SM Tech Limited
KQ:900070
Korea ₩35.90 Billion
DAEMO Engineering Co. Ltd
KQ:317850
Korea ₩18.23 Billion
Co2 Capsol AS
OL:CAPSL
Norway Nkr42.19 Million
Zenith Energy Ltd
OL:ZENA
Norway Nkr103.26 Million
VBARE Iberian Properties SOCIMI SA
MC:YVBA
Spain €25.26 Million
Qmines Ltd
AU:QML
Australia AU$2.66 Million
Killi Resources Ltd
AU:KLI
Australia AU$90.10K
Wolford Aktiengesellschaft
VI:WOL
Austria €201.77 Million

Liability Composition Analysis (2006–2025)

This chart breaks down SANUWAVE Health, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SANUWAVE Health, Inc. Common Stock (SNWV) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.31 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 19.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.95 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SANUWAVE Health, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SANUWAVE Health, Inc. Common Stock (2006–2025)

The table below shows the annual total liabilities of SANUWAVE Health, Inc. Common Stock from 2006 to 2025.

Year Total Liabilities Change
2025-12-31 $35.72 Million -16.60%
2024-12-31 $42.84 Million -34.70%
2023-12-31 $65.59 Million +7.74%
2022-12-31 $60.88 Million +5.74%
2021-12-31 $57.58 Million +56.69%
2020-12-31 $36.75 Million +173.30%
2019-12-31 $13.45 Million -18.68%
2018-12-31 $16.53 Million +48.16%
2017-12-31 $11.16 Million +40.97%
2016-12-31 $7.92 Million +15.80%
2015-12-31 $6.84 Million +9.95%
2014-12-31 $6.22 Million -19.42%
2013-12-31 $7.72 Million -7.81%
2012-12-31 $8.37 Million +8.66%
2011-12-31 $7.70 Million -43.13%
2010-12-31 $13.55 Million +15.27%
2009-12-31 $11.75 Million +15322.39%
2008-12-31 $76.20K +47.75%
2007-12-31 $51.57K +25.93%
2006-12-31 $40.95K --

About SANUWAVE Health, Inc. Common Stock

NASDAQ:SNWV USA Medical Devices
Market Cap
$35.51 Million
Market Cap Rank
#23270 Global
#5078 in USA
Share Price
$4.13
Change (1 day)
-2.13%
52-Week Range
$4.00 - $16.47
All Time High
$16.47
About

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more